PropertyValue
?:abstract
  • To circumvent the devastating pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, a humanized decoy antibody (ACE2-Fc fusion protein) was designed to target the interaction between viral spike protein and its cellular receptor, angiotensin-converting enzyme 2 (ACE2) First, we demonstrated that ACE2-Fc could specifically abrogate virus replication by blocking the entry of SARS-CoV-2 spike-expressing pseudotyped virus into both ACE2-expressing lung cells and lung organoids The impairment of viral entry was not affected by virus variants, since efficient inhibition was also observed in six SARS-CoV-2 clinical strains, including the D614G variants which have been shown to exhibit increased infectivity The preservation of peptidase activity also enables ACE2-Fc to reduce the angiotensin II-mediated cytokine cascade Furthermore, this Fc domain of ACE2-Fc was shown to activate NK cell degranulation after coincubation with Spike-expressing H1975 cells These promising characteristics potentiate the therapeutic prospects of ACE2-Fc as an effective treatment for COVID-19
is ?:annotates of
?:creator
?:journal
  • EMBO_Mol_Med
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection
?:type
?:who_covidence_id
  • #914845
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/ubzrfhg9>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/ubzrfhg9>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all